PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27590241-7	2016	Moreover, intracellular Ang II (100 nM), by itself, reduced the potassium current, an effect decreased by intracellular valsartan (100 nM).	Valsartan	120-129	angiogenin	Rattus norvegicus	24-27	
27590241-8	2016	Valsartan (10-9 M) dialyzed into the cell abolished the effect of Ang-(1-12) (100 nM).	Valsartan	0-9	angiogenin	Rattus norvegicus	66-69	
23141017-8	2012	(4) Valsartan not only attenuated the proliferation of VSMC and the intimal thickening but also upregulated the expression of ACE2 and the level of Ang(1-7) and downregulated the expression of AT(1)R and the level of AngII, p-ERK in this model.	Valsartan	4-13	angiogenin	Rattus norvegicus	148-155	
26887263-11	2015	Pre-treatment with Valsartan, TCS HDAC6 20b or Ac-SDKP could inhibited all this changes induced by Ang II in vitro.	Valsartan	19-28	angiogenin	Rattus norvegicus	99-102	
23141017-9	2012	CONCLUSION: Intimal thickening after balloon injury is linked with reduced expression of ACE2.Valsartan can inhibit the intimal thickening possibly by upregulating ACE2 and Ang(1-7) and downregulating AT(1) in this model.	Valsartan	94-103	angiogenin	Rattus norvegicus	173-180	
12895663-7	2003	The reduced metabolism of Ang III may prolong its half-life in valsartan-treated animals.	Valsartan	63-72	angiogenin	Rattus norvegicus	26-29	
21056585-7	2011	KEY FINDINGS: In the presence of AT(1)-antagonist valsartan, Ang II induced vasodilatation, which was more pronounced in the arteries incubated with Ile-Pro-Pro (P<0.05) compared to the other compounds.	Valsartan	50-59	angiogenin	Rattus norvegicus	61-64	
16220196-15	2005	Valsartan and PD98059 blocked Ang II-stimulated ERK activation.	Valsartan	0-9	angiogenin	Rattus norvegicus	30-33	
18619357-11	2008	If tanshinone II or valsartan was added to the culture medium before Ang II, both of them could inhibit the increase of c-fos, c-jun mRNA expression (P < 0.01), cardiomyocyte protein synthesis rate (P < 0.01), and cardiomyocyte size (P < 0.05) induced by Ang II.	Valsartan	20-29	angiogenin	Rattus norvegicus	69-72	
16940708-9	2006	An MTS assay revealed that Ang II treatment significantly decreased the functional activity in BM-EPCs, and this effect was significantly reversed by valsartan.	Valsartan	150-159	angiogenin	Rattus norvegicus	27-30